For over 50 years, cannabis research has been limited to marijuana from one federal-approved facility in Mississippi.

The DEA now states that more companies can provide marijuana for research, eliminating obstacles to learning about the medical properties of narcotics.

“For example, I think it was difficult for (National Institute of Substance Abuse) (at least its program) to keep up with that trend, as the potency of street products increased to 12% 15%,” said Dr. Igor Grant. I will. Director of the Medical Cannabis Research Center at the University of California, San Diego.

Grant also states that it is difficult for a single company to keep up with the demand from researchers across the country.

He also said the new DEA policy would increase the diversity of research products. Previously, researchers could…

Read Full Article Here